发明名称 Anti-SSX-2 T cell receptors and related materials and methods of use
摘要 The invention provides an isolated or purified T cell receptor (TCR) having antigenic specificity for synovial sarcoma X Breakpoint (SSX)-2. The invention further provides related polypeptides and proteins, as well as related nucleic acids, recombinant expression vectors, host cells, and populations of cells. Further provided by the invention are antibodies, or an antigen binding portion thereof, and pharmaceutical compositions relating to the TCRs of the invention. Methods of detecting the presence of cancer in a host and methods of treating or preventing cancer in a host are further provided by the invention.
申请公布号 US9345748(B2) 申请公布日期 2016.05.24
申请号 US201113820802 申请日期 2011.09.14
申请人 The United States of America, as represented by the Secretary, Department of Health and Human Services 发明人 Morgan Richard A.;Chinnasamy Nachimuthu;Rosenberg Steven A.
分类号 A61K39/00;A61K38/17;C07K14/725;A61K31/706;A61K38/08;A61K38/10;C07K16/28 主分类号 A61K39/00
代理机构 Leydig, Voit & Mayer 代理人 Leydig, Voit & Mayer
主权项 1. An isolated or purified T cell receptor (TCR) comprising the amino acid sequences of SEQ ID NOs: 13-18, SEQ ID NO: 21 and SEQ ID NO: 22, wherein the TCR has antigenic specificity for synovial sarcoma X Breakpoint (SSX)-2 (SEQ ID NO: 1) presented in the context of an HLA-A2 molecule, wherein the TCR also recognizes SSX-4 (SEQ ID NO: 4), and wherein the TCR is a human/mouse chimeric TCR.
地址 Washington DC US
您可能感兴趣的专利